4 Key Facts on Meningococcal Disease that Parents Should Know During the Back-to-School Season

It’s the beginning of the school year and while students are settling into the classroom, many parents are working to keep their children on top of everything they need to be successful. With so much to do, it’s no wonder it can be overwhelming. Whether it’s high school or college, parents are trying to help get their teen prepared by purchasing pens and notebooks, bookbags and accessories, and even SAT guides and index cards. And, while those things are important, parents may not be aware two particularly crucial items for their school year—two separate vaccines to help protect adolescents and teens against meningococcal disease.

Teens and adolescents are one of the more at-risk populations given their phase of life. Because they can carry these bacteria in the back of the throat, innocent and typical behavior for teens such as sharing a drink or meal, or even a kiss with their significant other, could lead to the transmission of bacteria that cause this uncommon but serious disease.3 Below are key facts to help keep your teen healthy as you navigate the school year:

  • Meningococcal disease is an uncommon, but serious disease that can attack without warning.4,5 Meningococcal disease can lead to meningitis (inflammation of the protective membranes that cover the brain and spinal cord) and serious blood infections.5
  • It’s important for parents of adolescents and teens to be aware that there are two separate vaccines to help protect against different groups of meningococcal disease: one vaccine that helps protect against groups A, C, W and Y and a separate vaccine that helps protect against group B. These two vaccines are needed to help protect against the most common groups of meningococcal disease.8
  • Meningococcal group B (MenB) is an uncommon disease that accounted for nearly 69% of all U.S. meningococcal cases in 16- to 23-year-old adolescents and young adults in 2017.10 MenB can lead to death within 24 hours11,12 and in survivors may result in life-altering, significant long-term disabilities.8,11
  • The Centers for Disease Control and Prevention (CDC) recommends adolescents receive their first dose of a MenACWY vaccine between ages 11 and 12 and a booster dose at age 16.12 The CDC also recommends that parents and their teens talk to their doctor or pharmacist about receiving a MenB vaccination series starting at age 16.10

If you’re a parent and have questions about how to help protect your adolescent or teen against meningococcal disease, including MenB, the first and best step you can take is to talk to your child’s health care provider. To learn more, please visit www.MeetMeningitis.com. This is sponsored in partnership with Pfizer.


[1] Centers for Disease Control and Prevention. Meningococcal disease. Enhanced meningococcal disease surveillance report. Centers for Disease Control and Prevention website. https://www.cdc.gov/meningococcal/downloads/NCIRD-EMS-Report-2017.pdf. Accessed June 2019.

[2] Tully J, Viner RM, Coen FG, et al. Risk and protective factors for meningococcal disease in adolescents: matched cohort study. BMJ. 2006;232(7539):445-450.

[3] Poland GA. Prevention of meningococcal disease: current use of polysaccharide and conjugate vaccines. Clin Infect Dis. 2010;50:S45-S53.

[4] Serogroup B Meningococcal (MenB) VIS. Centers for Disease Control and Prevention (CDC) Website. https://www.cdc.gov/vaccines/hcp/vis/vis-statements/mening-serogroup.html. Updated August 9, 2016. Accessed June 2019.

[5] Soeters H, McNamara L, Blain A, et al. University-Based Outbreaks of Meningococcal Disease Caused by Serogroup B, United States, 2013–2018. Centers for Disease Control and Prevention. https://wwwnc.cdc.gov/eid/article/25/3/18-1574_article. Accessed June 2019.

[6] Walker, TY, et al. (2019). National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2018. Accessed at https://www.cdc.gov/mmwr/volumes/68/wr/pdfs/mm6833a2-H.pdf. MMWR. Morbidity and Mortality Weekly Report. 68(33): 718-723.

[7] Enhanced meningococcal disease surveillance report, 2017. Centers for Disease Control and Prevention. https://www.cdc.gov/meningococcal/downloads/NCIRD-EMS-Report-2017.pdf. Accessed June 2019.

[8] Meningococcal Vaccines for Preteens, Teens. Centers for Disease Control and Prevention. http://www.cdc.gov/features/meningococcal/. Accessed June 2019.

[9] Thompson MJ, Ninis N, Perera R, et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet. 2006;367(9508):397-403.

[10] Borg J, Christie D, Coen PG, Pooy R, Viner RM. Outcomes of meningococcal disease in adolescence: prospective, matched-cohort study. Pediatrics. 2009;123:e502-e509.

[11] Sabatini C, Bosis S, Semino M, Senatore L, Principi N, Esposito S. Clinical presentation of meningococcal disease in childhood. J Prev Med Hyg. 2012;53:116-119.

[12] Recommended Child and Adolescent Immunization Schedule for ages 18 years or younger. US Department of Health and Human Services. Centers for Disease Control and Prevention. https://www.cdc.gov/vaccines/schedules/downloads/child/0-18yrs-child-combined-schedule.pdf. Accessed June 2019.

Speak Your Mind